![Robert Howes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Howes
Nessuna posizione attualmente
Storia della carriera di Robert Howes
Precedenti posizioni note di Robert Howes
Società | Posizione | Inizio | Fine |
---|---|---|---|
VERNALIS | Corporate Officer/Principal | 01/01/2001 | - |
Stanford University | Corporate Officer/Principal | - | - |
University of Cambridge | Corporate Officer/Principal | - | - |
Horizon Discovery Ltd.
![]() Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 01/06/2008 | - |
Formazione di Robert Howes
University of Cambridge | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Horizon Discovery Ltd.
![]() Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Ligand UK Ltd.
![]() Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Robert Howes
- Esperienza